An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the ...

The Food and Drug Administration unexpectedly canceled an annual meeting of its advisers to update next season's influenza ...

The federal agency, which is now overseen by a vaccine skeptic, did not offer a reason for the cancellation. It was slated to ...

The March meeting was set to vote on which flu strains would offer the most protection for next season’s flu shot.

VRBPAC members were alerted that the meeting was canceled in an email from the FDA that did not include an explanation, ...

The Food and Drug Administration (FDA) abruptly canceled a vaccine advisory meeting where members were slated to discuss influenza vaccine strains. The meeting was scheduled for March 13.

The FDA's decision to cancel the March meeting raises questions about flu vaccine guidance for manufacturers this year ...

A meeting of FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) that selects strains to include in ...

The FDA canceled a meeting of vaccine advisors scheduled for next month to decide the composition of next season's influenza ...

The Food and Drug Administration unexpectedly canceled an annual meeting of its advisers to update next season's influenza vaccines, an adviser on the panel and multiple officials tell CBS News ...

The advisory committee meeting is a critical resource for vaccine makers trying to figure out which flu strains to include in ...

Each year, flu vaccines are tailored to match the most prevalent virus strains expected to circulate. Without an official ...